The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats

The last decade has seen major advances in neuroscience tools allowing us to selectively modulate cellular pathways in freely moving animals. Chemogenetic approaches such as designer receptors exclusively activated by designer drugs (DREADDs) permit the remote control of neuronal function by systemic drug administration. These approaches have dramatically advanced our understanding of the neural control of behaviour. Here, we review the different techniques and genetic approaches available for the restriction of chemogenetic receptors to defined neuronal populations. We highlight the use of a dual virus approach to target specific circuitries and the effectiveness of different routes of administration of designer drugs. Finally, we discuss the potential caveats associated with DREADDs including off‐target effects of designer drugs, the effects of chronic chemogenetic receptor activation and the issue of collateral projections associated with DREADD activation and inhibition.

[1]  Alasdair J. G. Gray,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY , 2017, Nucleic Acids Res..

[2]  E. Callaway,et al.  Selective and Quickly Reversible Inactivation of Mammalian Neurons In Vivo Using the Drosophila Allatostatin Receptor , 2006, Neuron.

[3]  Dipendra K. Aryal,et al.  Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons , 2016, Neuropsychopharmacology.

[4]  E. Callaway,et al.  A Genetic Method for Selective and Quickly Reversible Silencing of Mammalian Neurons , 2002, The Journal of Neuroscience.

[5]  Brandon K. Harvey,et al.  Chemogenetics revealed: DREADD occupancy and activation via converted clozapine , 2017, Science.

[6]  B. Roth,et al.  Pharmacosynthetics: Reimagining the pharmacogenetic approach , 2013, Brain Research.

[7]  Shingo Tanaka,et al.  Double Virus Vector Infection to the Prefrontal Network of the Macaque Brain , 2015, PloS one.

[8]  B. Richmond,et al.  Disruption of relative reward value by reversible disconnection of orbitofrontal and rhinal cortex using DREADDs in rhesus monkeys , 2015, Nature neuroscience.

[9]  J. Wess,et al.  Design and Functional Characterization of a Novel, Arrestin-Biased Designer G Protein-Coupled Receptor , 2012, Molecular Pharmacology.

[10]  Prachi Khare,et al.  Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments , 2016, eNeuro.

[11]  J. Glorioso,et al.  Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector. , 1989, Gene.

[12]  Karl Deisseroth,et al.  Optogenetics in Neural Systems , 2011, Neuron.

[13]  M. Chillón,et al.  Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles , 2013, PloS one.

[14]  C. Caskey,et al.  An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  V. Gradinaru,et al.  Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems , 2017, Nature Neuroscience.

[16]  Anirvan Ghosh,et al.  Chemogenetic Synaptic Silencing of Neural Circuits Localizes a Hypothalamus→Midbrain Pathway for Feeding Behavior , 2014, Neuron.

[17]  C. Bass,et al.  Targeted genetic manipulations of neuronal subtypes using promoter-specific combinatorial AAVs in wild-type animals , 2015, Front. Behav. Neurosci..

[18]  B. Richmond,et al.  Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors , 2016, The Journal of Neuroscience.

[19]  Richard C Saunders,et al.  Chemogenetic disconnection of monkey orbitofrontal and rhinal cortex reversibly disrupts reward value , 2015, Nature Neuroscience.

[20]  Edward H. Nieh,et al.  Amygdala inputs to prefrontal cortex guide behavior amid conflicting cues of reward and punishment , 2017, Nature Neuroscience.

[21]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview , 2017, British journal of pharmacology.

[22]  Yasuyuki Kimura,et al.  PET imaging-guided chemogenetic silencing reveals a critical role of primate rostromedial caudate in reward evaluation , 2016, Nature Communications.

[23]  S. Rumpel,et al.  Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain , 2013, PloS one.

[24]  L. Zweifel,et al.  Manipulating Gene Expression in Projection‐Specific Neuronal Populations Using Combinatorial Viral Approaches , 2013, Current Protocols in Neuroscience.

[25]  N Freemantle,et al.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis , 2000, BMJ : British Medical Journal.

[26]  Lili Wang,et al.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Jann,et al.  Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  G. Aston-Jones,et al.  Dorsal Hippocampus Drives Context-Induced Cocaine Seeking via Inputs to Lateral Septum , 2018, Neuropsychopharmacology.

[29]  M. Nicolelis,et al.  Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors , 2009, Neuron.

[30]  B. Roth,et al.  Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization , 2010, Nature Neuroscience.

[31]  Roger A. H. Adan,et al.  Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo , 2014, PloS one.

[32]  Damien A. Fair,et al.  The Rhesus Monkey Connectome Predicts Disrupted Functional Networks Resulting from Pharmacogenetic Inactivation of the Amygdala , 2016, Neuron.

[33]  A. Goodchild,et al.  Excessive Respiratory Modulation of Blood Pressure Triggers Hypertension. , 2017, Cell metabolism.

[34]  K. Kissa,et al.  Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. English,et al.  Chemogenetic enhancement of functional recovery after a sciatic nerve injury , 2017, The European journal of neuroscience.

[36]  Matthew R Bailey,et al.  Decreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action , 2016, The Journal of Neuroscience.

[37]  J. Wess,et al.  Engineering GPCR signaling pathways with RASSLs , 2008, Nature Methods.

[38]  Jian Hua Li,et al.  A chemical-genetic approach to study G protein regulation of β cell function in vivo , 2009, Proceedings of the National Academy of Sciences.

[39]  Shuyun Dong,et al.  Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs , 2010, Nature Protocols.

[40]  W. Jagust,et al.  Safety and tolerability of putaminal AADC gene therapy for Parkinson disease , 2009, Neurology.

[41]  S. Cooper,et al.  Remote Control , 2002, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[42]  Joanna Oi-Yue Yau,et al.  Pharmacogenetic Excitation of Dorsomedial Prefrontal Cortex Restores Fear Prediction Error , 2015, The Journal of Neuroscience.

[43]  Hyunah Choo,et al.  The First Structure–Activity Relationship Studies for Designer Receptors Exclusively Activated by Designer Drugs , 2015, ACS chemical neuroscience.

[44]  Kerstin Steiner,et al.  Recent advances in rational approaches for enzyme engineering , 2012, Computational and structural biotechnology journal.

[45]  R. Fässler,et al.  Cre recombinase induces DNA damage and tetraploidy in the absence of LoxP sites , 2014, Cell cycle.

[46]  B. Roth,et al.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.

[47]  Alice M Stamatakis,et al.  Distinct extended amygdala circuits for divergent motivational states , 2013, Nature.

[48]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors , 2017, British journal of pharmacology.

[49]  Xiangmin Xu,et al.  Cell-type specific inactivation of hippocampal CA1 disrupts location-dependent object recognition in the mouse. , 2013, Learning & memory.

[50]  O. Danos,et al.  Canine Adenovirus Vectors: an Alternative for Adenovirus-Mediated Gene Transfer , 2000, Journal of Virology.

[51]  C. Strader,et al.  Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.

[52]  C. Cepeda,et al.  Basolateral Amygdala to Orbitofrontal Cortex Projections Enable Cue-Triggered Reward Expectations , 2017, The Journal of Neuroscience.

[53]  Adam J Pawson,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters , 2017, British journal of pharmacology.

[54]  Cailian Cui,et al.  Glutamatergic Projections from the Entorhinal Cortex to Dorsal Dentate Gyrus Mediate Context-Induced Reinstatement of Heroin Seeking , 2017, Neuropsychopharmacology.

[55]  Steven P. Wilson,et al.  Designer Receptors Show Role for Ventral Pallidum Input to Ventral Tegmental Area in Cocaine Seeking , 2014, Nature Neuroscience.

[56]  Thomas E Prisinzano,et al.  Role of Ventral Subiculum in Context-Induced Relapse to Alcohol Seeking after Punishment-Imposed Abstinence , 2016, The Journal of Neuroscience.

[57]  Jacob M. Hooker,et al.  Salvinorin A and derivatives: Protection from metabolism does not prolong short-term, whole-brain residence , 2009, Neuropharmacology.

[58]  L Naldini,et al.  Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector , 1997, Journal of virology.

[59]  Richard J. Miller,et al.  Chemogenetic Inhibition of Pain Neurons in a Mouse Model of Osteoarthritis , 2017, Arthritis & rheumatology.

[60]  L. Looger,et al.  A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons , 2016, Neuron.

[61]  A. Breckenridge,et al.  The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution , 2004, European Journal of Clinical Pharmacology.

[62]  T. Daigle,et al.  A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons , 2013, Neuropsychopharmacology.

[63]  B. Roth,et al.  Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats , 2016, Neuropsychopharmacology.

[64]  David J. Anderson,et al.  Reversible Silencing of Neuronal Excitability in Behaving Mice by a Genetically Targeted, Ivermectin-Gated Cl− Channel , 2007, Neuron.

[65]  Praneeth Namburi,et al.  Divergent Routing of Positive and Negative Information from the Amygdala during Memory Retrieval , 2016, Neuron.

[66]  Xi-Ping Huang,et al.  A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior , 2015, Neuron.

[67]  Christopher Southan,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand‐gated ion channels , 2017, British journal of pharmacology.

[68]  Gord Fishell,et al.  Reverse Pharmacogenetic Modulation of the Nucleus Accumbens Reduces Ethanol Consumption in a Limited Access Paradigm , 2014, Neuropsychopharmacology.

[69]  H. Meltzer,et al.  An overview of the mechanism of action of clozapine. , 1994, The Journal of clinical psychiatry.

[70]  Denis Smirnov,et al.  DREADD’ed Addiction: Using Designer Receptors to Delineate Neural Circuits Underlying Drug-Seeking Behaviors , 2015 .

[71]  B. Conklin,et al.  Development of Hydrocephalus in Mice Expressing the Gi-Coupled GPCR Ro1 RASSL Receptor in Astrocytes , 2007, The Journal of Neuroscience.

[72]  B. Roth,et al.  DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. , 2015, Annual review of pharmacology and toxicology.

[73]  L. Looger,et al.  Chemical and Genetic Engineering of Selective Ion Channel–Ligand Interactions , 2011, Science.

[74]  Shalini Jain,et al.  Chronic activation of a designer G(q)-coupled receptor improves β cell function. , 2013, The Journal of clinical investigation.

[75]  Adam J Pawson,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes , 2017, British journal of pharmacology.

[76]  Thomas Wichmann,et al.  Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics. , 2017, ACS chemical neuroscience.

[77]  O. Yizhar,et al.  The Anterior Insular Cortex→Central Amygdala Glutamatergic Pathway Is Critical to Relapse after Contingency Management , 2017, Neuron.

[78]  Eric Ravussin,et al.  Leptin Mediates the Increase in Blood Pressure Associated with Obesity , 2014, Cell.

[79]  B. Oldfield,et al.  The Role of Mesolimbic Reward Neurocircuitry in Prevention and Rescue of the Activity-Based Anorexia (ABA) Phenotype in Rats , 2017, Neuropsychopharmacology.

[80]  Christophe Magnan,et al.  Palatability Can Drive Feeding Independent of AgRP Neurons. , 2017, Cell metabolism.

[81]  H. Akil,et al.  Controlling signaling with a specifically designed Gi-coupled receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Michael J. Krashes,et al.  Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake , 2016, Nature Communications.

[83]  P M Alves,et al.  Evaluation of helper-dependent canine adenovirus vectors in a 3D human CNS model , 2015, Gene Therapy.

[84]  J. Lynch,et al.  An Improved Ivermectin-activated Chloride Channel Receptor for Inhibiting Electrical Activity in Defined Neuronal Populations* , 2010, The Journal of Biological Chemistry.

[85]  P. Chambon,et al.  A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse , 2003, Nature Biotechnology.

[86]  S. Sternson,et al.  A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping , 2008, The Journal of Neuroscience.